Ditchcarbon
  • Contact
  1. Organizations
  2. UCB, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

UCB, Inc. Sustainability Profile

Company website

UCB, Inc., a prominent biopharmaceutical company headquartered in the United States, has established itself as a leader in the development of innovative therapies for neurological and immunological disorders. Founded in 1928, UCB has achieved significant milestones, including the launch of groundbreaking treatments that address unmet medical needs. With a strong presence in North America and Europe, UCB focuses on core areas such as epilepsy, Parkinson's disease, and autoimmune conditions. Their unique approach combines advanced science with patient-centric solutions, setting them apart in the competitive biopharmaceutical landscape. Recognised for their commitment to research and development, UCB continues to enhance its market position through strategic partnerships and a robust pipeline of novel therapies.

DitchCarbon Score

How does UCB, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

92

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

UCB, Inc.'s score of 92 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.

95%

Let us know if this data was useful to you

UCB, Inc.'s reported carbon emissions

Inherited from UCB SA

UCB, Inc., headquartered in the US, currently does not report specific carbon emissions data for the latest year, as indicated by the absence of emissions figures. However, the company is part of a corporate family that includes UCB SA, from which it inherits climate commitments and initiatives. UCB SA has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). These commitments reflect a broader industry trend towards transparency and accountability in carbon emissions management. UCB, Inc. aligns with these initiatives, although specific reduction targets or achievements have not been disclosed. As a current subsidiary of UCB SA, UCB, Inc. is expected to adhere to the sustainability goals and climate strategies set forth by its parent company. This includes a commitment to reducing emissions across all scopes, although detailed figures and specific targets have not been provided in the available data. In summary, while UCB, Inc. does not present its own emissions data, it is linked to UCB SA's climate commitments, which are part of a growing movement within the pharmaceutical industry to address climate change and reduce carbon footprints.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2015201620172018201920202021202220232024
Scope 1
44,059,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
5,316,000
00,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000
Scope 3
568,003,000
00,000,000
00,000,000
00,000,000
00,000,000
000,000,000
000,000,000
000,000,000
00,000,000
000,000,000

How Carbon Intensive is UCB, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. UCB, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is UCB, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for UCB, Inc. is in US, which has a low grid carbon intensity relative to other regions.

UCB, Inc.'s Scope 3 Categories Breakdown

UCB, Inc.'s Scope 3 emissions, which increased significantly last year and increased by approximately 35% since 2015, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 90% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
90%
Upstream Transportation & Distribution
4%
Business Travel
3%
Fuel and Energy Related Activities
1%
Employee Commuting
<1%
End-of-Life Treatment of Sold Products
<1%
Waste Generated in Operations
<1%
Upstream Leased Assets
<1%

UCB, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

UCB, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare UCB, Inc.'s Emissions with Industry Peers

Mylan, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Genentech

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Bedford Laboratories

US
Updated about 1 month ago

Antares Pharma, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Hospira

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Astellas Pharma Ltd.

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251031.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy